查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844063

心血管手術器械市場按產品類型、應用、最終用戶和材料分類－2025-2032年全球預測

Cardiac Surgery Instruments Market by Product Type, Application, End User, Material - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心血管手術器械市場規模將達到 4,098 億美元，複合年成長率為 11.56%。

關鍵市場統計數據
基準年 2024 1707.8億美元
預計年份：2025年 1909.6億美元
預測年份 2032 4098億美元
複合年成長率 (%) 11.56%

分析心血管手術器材市場格局，說明器材創新、臨床需求和採購動態如何影響策略決策。

在器械創新、手術流程變革和供應鏈韌性等複雜因素的共同作用下，心血管手術器械生態系統日趨成熟。本執行摘要總結了當前的市場動態，並重點闡述了影響臨床和商業策略的最重要發展。本文將技術進步置於不斷變化的手術流程偏好、監管監督和材料科學進步的背景下進行分析，這些因素共同影響著採購、臨床結果和供應商競爭。

臨床醫生持續要求醫療器材能夠實現更高的精準度、更短的手術時間和更可預測的止血效果，而醫院系統則優先考慮器械的耐用性、成本控制和庫存合理化。因此，製造商正積極回應，推出模組化產品架構、先進的生物材料和整合式手術系統，旨在降低術中操作的複雜性。隨著該領域的不斷發展，臨床、監管和製造領域的跨部門合作將決定哪些創新能夠成為標準療法，哪些只能作為輔助。本導言將探討變革性轉變、關稅的影響、細分市場的具體考慮、區域動態、競爭定位、可操作的建議以及支持本檢驗的調查方法。

心胸外科器械研發、手術操作和供應鏈策略的關鍵變革將重新定義臨床和商業性價值創造。

一系列變革性變化正在重塑心臟外科手術器械的臨床實踐和商業性模式。生物材料和合成移植物工程的進步提高了生物相容性和長期耐久性；電外科技術的改進和泵技術的提升減少了術中創傷並改善了灌注控制；而器械模組化和數位化整合的融合則實現了更智慧的器械選擇和術中反饋迴路，為臨床醫生提供數據，以指導即時決策和術後品質評估。

同時，外科技術的不斷發展，包括微創手術和混合手術的興起，正在改變產品需求格局，推動對體積更小、適應性更強的器械和瓣膜解決方案的需求。供應鏈的韌性和生產的靈活性已成為市場參與企業的核心優先事項，促使他們投資建造區域製造中心並採用雙源籌資策略。總而言之，這些轉變正在重新定義買家的價值等式，為那些能夠證明其產品能夠經臨床驗證改善患者預後並具有可預測成本曲線的製造商創造了機會。

2025年關稅政策的變化將如何推動心臟醫療設備生態系統的供應鏈重組、生產在地化以及整體擁有成本的重新評估？

2025年關稅的實施將為全球採購流程帶來顯著的摩擦，迫使醫院、手術網路和設備供應商重新評估籌資策略和成本分攤機制。關稅的實施提高了本地生產和近岸外包的相對吸引力，加速了關於重組生產基地和供應商多元化的討論。因此，採購團隊正專注於整體擁有成本，包括關稅、物流、庫存持有成本以及供應商整合或替代對其營運的影響。

為此，一些製造商正在調整合約條款，並探索關稅緩解策略，例如關稅工程、關稅分類審查以及提高生產本地化程度。這些措施旨在維持價格競爭力，同時確保供應可靠性。此外，關稅環境促使人們重新關注產品合理化，迫使醫療服務提供者簡化設備處方流程，並優先考慮可跨越不同適應症且不會大幅增加關稅的多用途平台。這些因素累積作用，導致策略重點轉變，更加重視供應鏈韌性、生產彈性以及在不斷變化的貿易環境下展現可預測的成本結構。

深度細分智慧揭示產品類型、臨床應用、最終用戶環境和材料類別如何相互交織，從而驅動差異化需求。

基於細分市場的分析揭示了不同產品類型、臨床應用、終端用戶和材料類別之間的差異化需求模式和競爭動態。依產品類型分類，主動脈移植物分為兩類：生物移植物，其重點在於與宿主整合；以及合成移植物，其重點在於長期耐用性。心肺體外迴圈系統在性能預期方面存在顯著差異：離心式幫浦系統，其重點在於減少血液損傷；而滾壓泵系統，其重點在於易用性和成本效益。電外科設備分為雙極設備和單極設備，前者可提供高能量輸出，後者則繼續滿足各種外科手術需求。外科縫合線和縫合釘包括用於臨時傷口支撐的可吸收縫合線、永久性縫合的不可吸收縫合線以及用於快速閉合的縫合釘。血管閉合解決方案包括用於機械閉合的血管夾和用於輔助止血的血管密封劑。

主動脈瘤修復分為血管內修復和開放性手術，兩者所需的器械各不相同。先天性心臟缺陷矯正強調器械的小型化和精準性，尤其適用於房間隔缺損（ASD）和室間隔缺損（VSD）的封堵手術。冠狀動脈繞道手術手術（CABG）繼續支援非體外循環和體外循環兩種手術流程，每種流程都需要特定的器械。心臟瓣膜修復和置換強調主動脈瓣修復和二尖瓣修復所需的器械特性不同。終端使用者群體涵蓋門診手術中心、醫院和專科診所，每個機構都有其自身的採購週期、庫存限制和臨床吞吐量預期。材料分類—生物材料、金屬材料和聚合物材料—影響著監管路徑、滅菌通訊協定和使用者偏好。了解這些細分維度之間的交集對於協調產品開發、臨床證據產生和商業性打入市場策略至關重要。

美洲、歐洲、中東和非洲以及亞太地區的區域動態和市場准入現狀將影響臨床應用和商業性成功。

區域動態對臨床應用模式、監管路徑和商業策略有顯著影響。在美洲，需求主要受醫院系統整合、對手術效率的重視以及支付方對臨床和經濟價值的嚴格審查所驅動。這種環境有利於那些兼具臨床差異化優勢、可預測的供應鏈和長期維護支援的醫療器材。歐洲、中東和非洲地區是一個異質性區域，既面臨挑戰也蘊藏著獨特的機遇，包括監管協調、醫療基礎設施的多樣性以及不斷變化的報銷政策。在這些市場取得成功往往取決於強大的本地夥伴關係和靈活的定價模式。在亞太地區，產能的快速擴張、對微創手術基礎設施的投資以及對本土製造的日益重視，正在打造一個充滿活力的市場，能夠滿足該地區獨特臨床需求和監管要求的靈活製造商將獲得豐厚的回報。

這些區域差異需要量身定做的商業性策略，從臨床證據生成策略到對經銷夥伴和本地化生產的投資，都應如此。製造商若能產品系列與區域手術偏好相契合，並投資於監管專業知識和針對特定市場的臨床醫生互動，將更有利於在不同地區獲取長期價值。

心血管手術器材製造商與專業創新者之間的競爭動態和策略夥伴關係推動了創新、市場進入和臨床應用。

心臟外科器械市場的競爭格局由成熟的器材製造商、新興的專業創新者以及加速臨床檢驗和分銷管道拓展的策略夥伴關係關係共同塑造。大型公司通常透過整合解決方案、豐富的產品系列以及對臨床證據和上市後監測的持續投入來脫穎而出。同時，一些專注於特定領域的企業則傾向於利用專業技術解決特定手術中的痛點，例如用於複雜血管閉合的純化密封劑或具有更佳操作性能的新一代縫合線，從而在臨床上站穩腳跟。

策略聯盟和收購對於整合技術能力和拓展地域覆蓋範圍仍然至關重要。醫療器材製造商與臨床研究網路之間的合作有助於更快地產生證據並改善產品推廣應用，而與契約製造製造商和物流供應商的合作則能增強供應鏈的韌性。儘管擁有強大臨床資料集、可擴展生產能力和靈活商業模式的市場現有企業仍保持著明顯的競爭優勢，但能夠在特定應用場景中展現出顯著的流程優勢和成本效益的創新企業，則能夠迅速顛覆既有的市場格局。

針對產業領導者，聚焦臨床證據、生產敏捷性、模組化平台和先進商業模式，提出切實可行的策略要務。

產業領導者應採取多管齊下的策略，將產品創新與臨床工作流程整合、監管前瞻性和供應鏈韌性結合。首先，投資轉化臨床研究，將設備性能與諸如縮短手術時間、降低併發症發生率和改善患者康復軌跡等有意義的臨床結果聯繫起來。此類證據不僅支持臨床應用，還能加強與支付方和醫院系統基本契約談判。其次，優先考慮靈活的製造地和近岸外包方案，以減輕關稅和物流波動的影響，同時能夠快速回應區域需求變化。第三，在設計產品平台時應考慮模組化，使一個核心系統能夠應用於多種手術，從而簡化機構投資者的採購和庫存管理。

此外，透過有針對性的培訓、基於模擬的入職培訓和共用結果追蹤，深化​​與臨床醫生的夥伴關係，以增強用戶信心並收集真實世界證據。最後，盡可能採用訂閱或基於結果的定價模式，為購買者提供可預測的預算，並為製造商提供持續的收入來源。透過協調臨床證據、生產靈活性和前瞻性的商業性策略，行業領導者可以在不斷變化的市場中獲得永續優勢。

透過嚴謹的混合方法研究途徑，結合臨床醫生訪談、監管調查和供應鏈分析，檢驗了臨床和商業性的見解。

本分析的調查方法結合了定性和定量方法，以確保其全面性和平衡性。主要資料來源包括對心臟外科醫生、醫院採購負責人、臨床工程師和製造企業高管的訪談，以獲取關於器械性能、手術趨勢和採購行為的第一手觀點。此外，還對監管指南、臨床試驗報告和衛生技術評估報告進行了結構化審查，以支持臨床和安全性的論述。

二次分析評估了公開的監管文件、產品概況和同行評審文獻，以識別技術進步和材料性能特徵。透過產業物流報告和供應商訪談評估了供應鏈和關稅的影響，以了解其對採購和生產決策的實際意義。在整個過程中，跨資料來源的輸入三角驗證和交叉檢驗為趨勢的可靠解讀提供了支持，專家評審確保結論反映了當前的臨床實踐和商業性現實。

對技術創新、供應鏈韌性和區域差異進行綜合分析，為心血管手術器械相關人員明確戰略要務。

總之，心血管手術器械市場正處於曲折點，其驅動力來自材料創新、手術流程的改進以及貿易動態的演變。生物材料的改良、電外科和灌注技術的進步，以及微創和混合手術模式的興起，正在不同產品類型和臨床應用領域催生差異化的需求。關稅相關的干擾凸顯了生產地接近性和供應鏈彈性的策略重要性，促使企業重新評估籌資策略，並將整體擁有成本置於優先地位。區域差異進一步加劇了競爭格局的複雜性，凸顯了製定在地化市場策略和深入了解監管法規的必要性。

未來，能夠將強力的臨床證據與敏捷的生產製造和靈活的商業模式相結合的製造商，將更有能力滿足從門診手術中心到三級醫院和專科診所等各類終端用戶的需求。與臨床醫生和供應鏈合作夥伴的策略合作將加速產品應用，並確保設備創新能為患者和醫療機構帶來可衡量的益處。成功之路清晰可見：優先考慮具有臨床意義的創新，建立穩健的供應鏈，並以結果為導向的價值主張吸引買家。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 快速整合病患特異性3D列印牽引與穩定裝置以進行精準心血管手術
  • 增加抗菌塗層微創手術鉗的使用，以降低術後感染率
  • 開發用於複雜開胸手術期間即時血流動力學分析的人工智慧灌注監測主機
  • 三級醫療中心使用機器人輔助內視鏡器械進行二尖瓣和三尖瓣修復手術的數量迅速增加
  • 推出適用於混合手術室的腹腔鏡工具包，以簡化心血管手術和介入手術的聯合手術。
  • 監管核准挑戰和報銷政策變化影響下一代環狀成形術環的市場進入
  • 為農村心血管手術計畫開發一個整合智慧器械手柄的遠距教學平台
  • 專為微創心血管組織修復應用而設計的生物可分解聚合物基縫合錨釘的出現

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章心血管手術器械市場（依產品類型分類）

  • 主動脈移植
    • 生物移植
    • 合成接枝
  • 心肺體外迴圈系統
    • 離心式幫浦系統
    • 滾筒幫浦系統
  • 電外科設備
    • 雙極元件
    • 單極儀器
  • 心臟瓣膜
    • 機械閥
    • 組織瓣膜
  • 外科縫合線和縫合釘
    • 可吸收縫線
    • 不可吸收縫線
    • 手術縫合釘
  • 血管閉合裝置
    • 血管夾
    • 血管密封劑

第9章心血管手術器械市場（依應用領域分類）

  • 主動脈瘤修復
    • 血管內修復
    • 開放性手術
  • 先天性心臟疾病矯正
    • ASD 閉合
    • 室間隔缺損封堵術
  • 冠狀動脈繞道手術手術
    • 非體外循環冠狀動脈繞道手術
    • 體外循環冠狀動脈繞道手術
  • 心臟瓣膜修復和置換
    • 主動脈瓣修補
    • 二尖瓣修復

第10章心血管手術器械市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第11章心血管手術器械市場（依材料分類）

  • 生物
  • 金屬系統
  • 聚合物

第12章 各地區心血管手術器械市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章心血管手術器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國心血管手術器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Johnson & Johnson
    • Abbott Laboratories
    • Getinge AB
    • Terumo Corporation
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Edwards Lifesciences Corporation
Product Code: MRR-AD36CD89859B

The Cardiac Surgery Instruments Market is projected to grow by USD 409.80 billion at a CAGR of 11.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 170.78 billion
Estimated Year [2025] USD 190.96 billion
Forecast Year [2032] USD 409.80 billion
CAGR (%) 11.56%

An authoritative framing of the cardiac surgery instruments landscape that contextualizes device innovation, clinical demand, and procurement dynamics shaping strategic decisions

The cardiac surgery instruments ecosystem has matured into a complex interplay of device innovation, procedural change, and supply chain resilience. This executive summary synthesizes the prevailing market dynamics and draws attention to the most consequential developments shaping clinical practice and commercial strategy. It frames the technological progress in a context of evolving procedural preferences, regulatory oversight, and material science advancements that collectively influence procurement, clinical outcomes, and vendor competitiveness.

Clinicians continue to demand devices that afford greater precision, shorter procedural times, and predictable hemostasis, while hospital systems prioritize durability, cost-control, and inventory rationalization. Consequently, manufacturers are responding with modular product architectures, refined biomaterials, and integrated surgical systems that aim to lower intraoperative complexity. As the sector progresses, collaboration across clinical, regulatory, and manufacturing domains will determine which innovations become standards of care versus niche adjuncts. This introduction sets the stage for the subsequent sections, which examine transformative shifts, tariff impacts, segmentation-specific insights, regional dynamics, competitive positioning, actionable recommendations, and the methodological approach underpinning the analysis.

Critical transformative shifts in cardiothoracic device development, procedural practice, and supply chain strategies that are redefining clinical and commercial value creation

A series of transformative shifts is reshaping both clinical practice and commercial approaches in cardiac surgery instrumentation. Advances in biomaterials and synthetic graft engineering are improving biocompatibility and long-term durability, while electrosurgical refinement and enhanced pump technologies are reducing intraoperative trauma and improving perfusion control. Meanwhile, the convergence of device modularity and digital integration enables smarter instrument selection and intraoperative feedback loops, providing clinicians with data that can inform real-time decisions and post-procedural quality assessments.

Concurrently, procedural evolution such as increased uptake of minimally invasive and hybrid approaches is altering product demand profiles, with enhanced demand for smaller footprint devices and adaptable valve solutions. Supply chain resilience and manufacturing agility have become central priorities for market participants, prompting investment in regional manufacturing hubs and dual-sourcing strategies. Collectively, these shifts are redefining the value equation for purchasers and creating opportunities for manufacturers that can demonstrate clinically substantiated improvements in outcomes alongside predictable cost curves.

How 2025 tariff policy shifts are compelling supply chain realignment, manufacturing localization, and total cost of ownership reassessments across the cardiac devices ecosystem

The introduction of tariffs in 2025 has introduced notable friction into global procurement flows, compelling hospitals, surgical networks, and device vendors to reassess sourcing strategies and cost allocation mechanisms. Tariff measures have increased the comparative attractiveness of local manufacturing and nearshoring, accelerating conversations about production footprint realignment and supplier diversification. As a result, procurement teams are emphasizing total cost of ownership considerations, including duties, logistics, inventory holding costs, and the operational impacts of supplier consolidation or substitution.

In response, several manufacturers have adjusted contractual terms and explored tariff-mitigation tactics such as tariff engineering, tariff classification reviews, and increased manufacturing localization. These approaches aim to preserve competitive pricing while maintaining supply reliability. Additionally, the tariff environment has stimulated renewed focus on product rationalization, compelling healthcare providers to streamline device formularies and prioritize multi-use platforms that can span procedural indications without incurring significant incremental duty exposure. The cumulative effect has been a reshuffling of strategic priorities that favors supply chain resilience, manufacturing flexibility, and the capacity to demonstrate predictable cost structures under changing trade regimes.

Deep segmentation intelligence revealing how product types, clinical applications, end-user settings, and material classes intersect to drive differentiated demand

Segmentation-driven insights reveal differentiated demand patterns and competitive dynamics across product types, clinical applications, end users, and material classes. Within product typologies, aortic grafts exhibit bifurcated requirements between biological grafts that prioritize host integration and synthetic grafts that emphasize long-term durability; cardiopulmonary bypass systems are marked by divergent performance expectations between centrifugal pump systems, prized for reduced blood trauma, and roller pump systems, valued for familiarity and cost-effectiveness. Electrosurgical devices separate into bipolar devices that offer focused energy delivery and monopolar devices that continue to serve broad surgical needs. Heart valves present a clear split between mechanical valves that deliver exceptional longevity and tissue valves that address anticoagulation concerns, while surgical sutures and staples cover absorbable sutures for transient wound support, non-absorbable sutures for permanent approximation, and staples for rapid closure. Vessel closure solutions span vascular clips for mechanical occlusion and vascular sealants for adjunct hemostasis.

Application-based distinctions further refine demand: aortic aneurysm repair differentiates endovascular repair from open surgery with distinct device profiles; congenital heart defect correction emphasizes device miniaturization and precision in ASD closure and VSD closure; coronary artery bypass grafting continues to support both off-pump CABG and on-pump CABG workflows, each dictating specific instrumentation; heart valve repair and replacement segments highlight different device attributes for aortic valve repair versus mitral valve repair. End user segmentation illustrates deployment contexts across ambulatory surgical centers, hospitals, and specialty clinics, each with unique procurement cycles, inventory constraints, and clinical throughput expectations. Material classification-biological products, metal instruments, and polymer instruments-shapes regulatory pathways, sterilization protocols, and user preferences. Understanding how these segmentation axes intersect is essential for tailoring product development, clinical evidence generation, and commercial go-to-market strategies.

Regional dynamics and market access realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical uptake and commercial success

Regional dynamics exert a profound influence on clinical adoption patterns, regulatory pathways, and commercial strategy. In the Americas, demand is driven by consolidated hospital systems, a focus on procedural efficiency, and payer scrutiny that rewards demonstrable clinical and economic value. This environment favors devices that combine clinical differentiation with predictable supply chains and long-term maintenance support. The Europe, Middle East & Africa region presents a heterogeneous landscape where regulatory harmonization, variable healthcare infrastructure, and evolving reimbursement policies create both challenges and niche opportunities; success in these markets is often predicated on strong local partnerships and adaptive pricing models. Across Asia-Pacific, rapid capacity expansion, investments in minimally invasive surgery infrastructure, and a growing focus on domestic manufacturing create a dynamic market that rewards agile manufacturers capable of addressing localized clinical needs and regulatory requirements.

These regional nuances require tailored commercial approaches, from clinical evidence generation strategies to distribution partnerships and localized manufacturing investments. Manufacturers that align product portfolios with regional procedural preferences and that invest in regulatory expertise and market-specific clinician engagement will be better positioned to capture long-term value in diverse geographies.

Competitive dynamics and strategic partnerships driving innovation, market entry, and clinical adoption across cardiac surgery device manufacturers and specialty innovators

Competitive landscapes in cardiac surgery instruments are shaped by a mix of established device manufacturers, emerging specialized innovators, and strategic partnerships that accelerate clinical validation and distribution reach. Leading firms typically differentiate through integrated solutions, broad product portfolios, and sustained investments in clinical evidence and post-market surveillance. Meanwhile, niche players frequently secure clinical footholds by addressing specific procedural pain points with focused technologies-such as refined sealants for complex vascular closures or next-generation sutures that improve handling characteristics.

Strategic alliances and acquisitions continue to be pivotal in consolidating technological capabilities and expanding geographic reach. Collaboration between device makers and clinical research networks facilitates faster evidence generation and improved adoption curves, while partnerships with contract manufacturers and logistics providers enhance supply chain resilience. Market incumbents that combine robust clinical datasets, scalable manufacturing, and flexible commercial models maintain distinct competitive advantages, though innovators that can demonstrate clear procedural benefits and cost-effectiveness in targeted use cases can rapidly disrupt established patterns.

Actionable strategic imperatives for industry leaders focusing on clinical evidence, manufacturing agility, modular platforms, and progressive commercial models

Industry leaders should pursue a multifaceted strategy that aligns product innovation with clinical workflow integration, regulatory foresight, and supply chain resilience. First, invest in translational clinical research that ties device performance to meaningful outcomes such as reduced operative time, lower complication rates, and improved patient recovery trajectories. Such evidence not only supports clinical adoption but also strengthens value-based contracting conversations with payers and hospital systems. Second, prioritize flexible manufacturing footprints and nearshoring options to mitigate tariff impacts and logistic volatility while enabling faster responsiveness to local demand shifts. Third, design product platforms with modularity in mind so that a single core system can be adapted across multiple procedures, thereby simplifying procurement and inventory management for institutional customers.

Additionally, cultivate deeper clinician partnerships through targeted training, simulation-based onboarding, and shared outcomes tracking to accelerate user confidence and to collect real-world evidence. Finally, adopt commercial models that allow for subscription or outcome-based pricing where feasible, offering predictable budgets for purchasers and recurring revenue streams for manufacturers. By synchronizing clinical evidence, manufacturing agility, and progressive commercial approaches, industry leaders can secure sustainable advantages in an evolving market.

A rigorous mixed-methods research approach combining clinician interviews, regulatory review, and supply chain analysis to validate clinical and commercial insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure comprehensive validity and balanced interpretation. Primary inputs included interviews with practicing cardiac surgeons, hospital procurement leaders, clinical engineers, and senior executives within manufacturing organizations to capture firsthand perspectives on device performance, procedural trends, and buying behaviors. These insights were complemented by a structured review of regulatory guidances, clinical trial publications, and health technology assessments to corroborate clinical and safety narratives.

Secondary analysis evaluated publicly available regulatory filings, product dossiers, and peer-reviewed literature to map technological advancements and material performance characteristics. Supply chain and tariff implications were assessed through industry logistics reports and supplier interviews to understand practical impacts on sourcing and manufacturing decisions. Throughout, triangulation of inputs and cross-validation between data sources supported a robust interpretation of trends, while expert review ensured that the conclusions reflect current clinical practice and commercial realities.

Concluding synthesis of innovation, supply chain resilience, and regional nuances that define strategic imperatives for cardiac surgery instrument stakeholders

In conclusion, the cardiac surgery instruments landscape is at an inflection point driven by material innovation, procedural evolution, and evolving trade dynamics. The convergence of improved biomaterials, refined electrosurgical and perfusion technologies, and a shift toward minimally invasive and hybrid procedures is creating differentiated demand across product categories and clinical applications. Tariff-related disruptions have elevated the strategic importance of manufacturing proximity and supply chain flexibility, prompting organizations to reassess sourcing strategies and to prioritize total cost of ownership. Regional variations further complicate the competitive calculus, underscoring the need for localized go-to-market strategies and regulatory acumen.

Looking ahead, manufacturers that pair compelling clinical evidence with agile manufacturing and adaptive commercial models will be best positioned to meet the needs of diverse end users-from ambulatory surgical centers to tertiary hospitals and specialty clinics. Strategic collaboration with clinicians and supply chain partners will accelerate adoption and ensure that device innovation translates into measurable patient and operational benefits. The pathways to success are clear: prioritize clinically meaningful innovation, build resilient supply chains, and engage purchasers with outcome-oriented value propositions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rapid integration of 3D-printed patient-specific retraction and stabilization devices for precision cardiac surgery
  • 5.2. Increasing adoption of antimicrobial-coated minimally invasive forceps to reduce postoperative infection rates in procedures
  • 5.3. Development of AI-powered perfusion monitoring consoles for real-time hemodynamic analysis during complex open-heart operations
  • 5.4. Surge in the use of robotic-assisted endoscopic instruments for mitral and tricuspid valve repair in tertiary care centers
  • 5.5. Deployment of hybrid operating room-compatible laparoscopic toolsets to streamline combined cardiac and interventional procedures
  • 5.6. Regulatory clearance challenges and reimbursement shifts shaping market access for next-generation annuloplasty rings
  • 5.7. Growth of tele-mentoring platforms integrated with smart instrument handles for remote guidance in rural cardiac surgery programs
  • 5.8. Emergence of biodegradable polymer-based suture anchors designed for minimally invasive cardiovascular tissue repair applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Surgery Instruments Market, by Product Type

  • 8.1. Aortic Grafts
    • 8.1.1. Biological Grafts
    • 8.1.2. Synthetic Grafts
  • 8.2. Cardiopulmonary Bypass Systems
    • 8.2.1. Centrifugal Pump Systems
    • 8.2.2. Roller Pump Systems
  • 8.3. Electrosurgical Devices
    • 8.3.1. Bipolar Devices
    • 8.3.2. Monopolar Devices
  • 8.4. Heart Valves
    • 8.4.1. Mechanical Valves
    • 8.4.2. Tissue Valves
  • 8.5. Surgical Sutures And Staples
    • 8.5.1. Absorbable Sutures
    • 8.5.2. Non-Absorbable Sutures
    • 8.5.3. Surgical Staples
  • 8.6. Vessel Closure Devices
    • 8.6.1. Vascular Clips
    • 8.6.2. Vascular Sealants

9. Cardiac Surgery Instruments Market, by Application

  • 9.1. Aortic Aneurysm Repair
    • 9.1.1. Endovascular Repair
    • 9.1.2. Open Surgery
  • 9.2. Congenital Heart Defect Correction
    • 9.2.1. ASD Closure
    • 9.2.2. VSD Closure
  • 9.3. Coronary Artery Bypass Grafting
    • 9.3.1. Off-Pump CABG
    • 9.3.2. On-Pump CABG
  • 9.4. Heart Valve Repair And Replacement
    • 9.4.1. Aortic Valve Repair
    • 9.4.2. Mitral Valve Repair

10. Cardiac Surgery Instruments Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Cardiac Surgery Instruments Market, by Material

  • 11.1. Biological Products
  • 11.2. Metal Instruments
  • 11.3. Polymer Instruments

12. Cardiac Surgery Instruments Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cardiac Surgery Instruments Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cardiac Surgery Instruments Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Johnson & Johnson
    • 15.3.3. Abbott Laboratories
    • 15.3.4. Getinge AB
    • 15.3.5. Terumo Corporation
    • 15.3.6. Stryker Corporation
    • 15.3.7. Zimmer Biomet Holdings, Inc.
    • 15.3.8. B. Braun Melsungen AG
    • 15.3.9. Baxter International Inc.
    • 15.3.10. Edwards Lifesciences Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CARDIAC SURGERY INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CARDIAC SURGERY INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIAC SURGERY INSTRUMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD